Pandemic Pulse Drug Updates

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Amsterdam: Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity and increase regional self-reliance. Highlighting […]

Pandemic Pulse

Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario

With an email to the main distributors, Copan group’s CEO describes how the ramp-up of Covid-19-related products has been concluded, and how the company is now reorganizing to face post-pandemic challenges. Last Tuesday, Copan partners received an email signed by Copan’s CEO Stefania Triva herself. Certainly, it was not the first email they received from the leader […]